Cited by 45Pregnancy and preeclampsia studiesBlood Pressure and Hypertension StudiesNeurological Complications and Syndromes

Hypertension in pregnancy: is it time for a new approach to treatment?

Open access
Moser, Marvin, Brown, Catherine M., Rose, Carl H., Garovic, Vesna D.·2012·Journal of Hypertension

Abstract

Hypertensive disorders represent major causes of pregnancy-related maternal mortality worldwide. The current definition and treatment recommendations for elevated blood pressure (BP) during pregnancy in the United States have remained unchanged for many years, unlike the recommendations for hypertension treatment in the general population. Clinical studies have provided convincing evidence that women with hypertensive pregnancy disorders are at both immediate and long-term risk for cardiovascular complications; these findings suggest that consideration be given to lowering the presently recommended BP thresholds, both for the initiation of therapy and for therapeutic targets, and to simplifying the approach to the management of elevated BP in pregnancy. This review focuses on the current treatment strategies for hypertensive pregnancy disorders, new developments in the field of hypertension, in general, and in pregnant patients, in particular, and their potential impact on contemporary BP goals and the use of specific antihypertensive medications in pregnancy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/hjh.0b013e3283536319

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Beta-adrenergic blocking agents have been studied extensively for treating hypertension in pregnancy, and no major side effects have been detected, although fetal growth restriction has been associated with prolonged use of especially atenolol.

    “These agents have been studied extensively when used for treating hypertension in pregnancy, and no major side effects have been detected, although fetal growth restriction has been associated with the prolonged use of especially atenolol (431,471).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Moser, M., Brown, C. M., Rose, C. H., & Garovic, V. D.
Affiliations
  • Yale University (US)
  • Mayo Clinic (US)
Corresponding author
Garovic, Vesna D.
Venue
Journal of Hypertension
Published
2012-06
Volume
30
Issue
6
Pages
1092-1100
ISSN
0263-6352 (ISSN-L)
OpenAlex
W2086901820
Cited by
45
References
66
Citations by year
2024: 1 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 2 · 2015: 4 · 2014: 8 · 2013: 6 · 2012: 2
FWCI
7.72
Type
journal article
Language
en
Open access
Locations
  • Journal of Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
Eunice Kennedy Shriver National Institute of Child Health and Human Development (K08HD051714)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Neurological Complications and Syndromes
Keywords
hypertension in pregnancy, hypertensive disorders of pregnancy, blood pressure thresholds, cardiovascular risk in pregnancy, maternal mortality, blood pressure targets, treatment guidelines
MeSH terms
Antihypertensive Agents, Blood Pressure, Female, Humans, Hypertension, Pregnancy, Pregnancy Complications, Cardiovascular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review